chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Eye pain, Headache, Myalgia
Clinical narrative: ringing in the ears; muscle and joint pain; joint pain; nausea; chills; headache; back of his eye and his skin hurt; back of his eye and his skin hurt; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOMFORT (back of his eye and his skin hurt), EYE PAIN (back of his eye and his skin hurt), TINNITUS (ringing in the ears), HEADACHE (headache) and MYALGIA (muscle and joint pain) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Positive) in July 2020.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced SKIN DISCOMFORT (back of his eye and his skin hurt), EYE PAIN (back of his eye and his skin hurt), HEADACHE (headache), ARTHRALGIA (joint pain), NAUSEA (nausea) and CHILLS (chills). On an unknown date, the patient experienced TINNITUS (ringing in the ears) and MYALGIA (muscle and joint pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SKIN DISCOMFORT (back of his eye and his skin hurt), EYE PAIN (back of his eye and his skin hurt), MYALGIA (muscle and joint pain), NAUSEA (nausea) and CHILLS (chills) had resolved, TINNITUS (ringing in the ears) and ARTHRALGIA (joint pain) outcome was unknown and HEADACHE (headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   This case was linked to MOD-2021-120806 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: New adverse event was added and email id was received. Lab test and medical history were added.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, SARS-CoV-2 test, Skin discomfort, Tinnitus
Clinical narrative: ringing in the ears; muscle and joint pain; joint pain; nausea; chills; headache; back of his eye and his skin hurt; back of his eye and his skin hurt; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOMFORT (back of his eye and his skin hurt), EYE PAIN (back of his eye and his skin hurt), TINNITUS (ringing in the ears), HEADACHE (headache) and MYALGIA (muscle and joint pain) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Positive) in July 2020.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced SKIN DISCOMFORT (back of his eye and his skin hurt), EYE PAIN (back of his eye and his skin hurt), HEADACHE (headache), ARTHRALGIA (joint pain), NAUSEA (nausea) and CHILLS (chills). On an unknown date, the patient experienced TINNITUS (ringing in the ears) and MYALGIA (muscle and joint pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SKIN DISCOMFORT (back of his eye and his skin hurt), EYE PAIN (back of his eye and his skin hurt), MYALGIA (muscle and joint pain), NAUSEA (nausea) and CHILLS (chills) had resolved, TINNITUS (ringing in the ears) and ARTHRALGIA (joint pain) outcome was unknown and HEADACHE (headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   This case was linked to MOD-2021-120806 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: New adverse event was added and email id was received. Lab test and medical history were added.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disorientation, Headache, Pyrexia
Clinical narrative: Disorientation; Low grade fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (Disorientation), PYREXIA (Low grade fever), CHILLS (Chills) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced DISORIENTATION (Disorientation), PYREXIA (Low grade fever), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, DISORIENTATION (Disorientation), PYREXIA (Low grade fever), CHILLS (Chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Updated the event outcome from unknown to resolved for all the reported events.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Received vaccine and he is 16 years old; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received vaccine and he is 16 years old) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received vaccine and he is 16 years old). On 15-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received vaccine and he is 16 years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products used were not reported. No treatment information reported; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old male) for mRNA-1273 (lot number 027A21A) with no associated AEs reported.
Sex: M
Vaccine: COVID19
Symptoms: Syringe issue, Underdose
Clinical narrative: feels like he got insufficient or zero quantity of the dose; The syringe leaked; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (feels like he got insufficient or zero quantity of the dose) and SYRINGE ISSUE (The syringe leaked) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced UNDERDOSE (feels like he got insufficient or zero quantity of the dose) and SYRINGE ISSUE (The syringe leaked). On 25-Mar-2021, UNDERDOSE (feels like he got insufficient or zero quantity of the dose) and SYRINGE ISSUE (The syringe leaked) had resolved.            No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: itchiness all over her body that comes and goes; hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) and PRURITUS (itchiness all over her body that comes and goes) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced URTICARIA (hives). On 21-Mar-2021, the patient experienced PRURITUS (itchiness all over her body that comes and goes). On 13-Mar-2021, URTICARIA (hives) had resolved. On 21-Mar-2021, PRURITUS (itchiness all over her body that comes and goes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included cetirizine.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 08-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Oral mucosal eruption, Vaccination site pain
Clinical narrative: Loose stool; Rash on mouth; Off balance woosy; Fatigue worsen; Pain in injection site right arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose stool), ORAL MUCOSAL ERUPTION (Rash on mouth), VERTIGO (Off balance woosy), FATIGUE (Fatigue worsen) and VACCINATION SITE PAIN (Pain in injection site right arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder. Concomitant products included THYROID (ARMOUR THYROID) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HEADACHE (Headache). On 15-Mar-2021, the patient experienced DIARRHOEA (Loose stool), ORAL MUCOSAL ERUPTION (Rash on mouth), VERTIGO (Off balance woosy), FATIGUE (Fatigue worsen) and VACCINATION SITE PAIN (Pain in injection site right arm). At the time of the report, DIARRHOEA (Loose stool), ORAL MUCOSAL ERUPTION (Rash on mouth), VERTIGO (Off balance woosy), FATIGUE (Fatigue worsen), VACCINATION SITE PAIN (Pain in injection site right arm) and HEADACHE (Headache) outcome was unknown.            No treatment information were reported.   This case was linked to MOD-2021-072987 (E2B Linked Report).; Sender's Comments:  MOD-2021-072987:2nd dose
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Loose stool; Rash on mouth; Off balance woosy; Fatigue worsen; Pain in injection site right arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose stool), ORAL MUCOSAL ERUPTION (Rash on mouth), VERTIGO (Off balance woosy), FATIGUE (Fatigue worsen) and VACCINATION SITE PAIN (Pain in injection site right arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder. Concomitant products included THYROID (ARMOUR THYROID) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HEADACHE (Headache). On 15-Mar-2021, the patient experienced DIARRHOEA (Loose stool), ORAL MUCOSAL ERUPTION (Rash on mouth), VERTIGO (Off balance woosy), FATIGUE (Fatigue worsen) and VACCINATION SITE PAIN (Pain in injection site right arm). At the time of the report, DIARRHOEA (Loose stool), ORAL MUCOSAL ERUPTION (Rash on mouth), VERTIGO (Off balance woosy), FATIGUE (Fatigue worsen), VACCINATION SITE PAIN (Pain in injection site right arm) and HEADACHE (Headache) outcome was unknown.            No treatment information were reported.   This case was linked to MOD-2021-072987 (E2B Linked Report).; Sender's Comments:  MOD-2021-072987:2nd dose
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Mammogram, Mammogram abnormal
Clinical narrative: Abnormal mammogram; This spontaneous case was reported by a consumer and describes the occurrence of MAMMOGRAM ABNORMAL (Abnormal mammogram) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced MAMMOGRAM ABNORMAL (Abnormal mammogram). On 22-Mar-2021, MAMMOGRAM ABNORMAL (Abnormal mammogram) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Mammogram: abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Facial pain, Pain in extremity
Clinical narrative: Sore arm; Pain in Left Cheek; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FACIAL PAIN (Pain in Left Cheek) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Herpes genital since an unknown date. Concomitant products included LEVOTHYROXINE, ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), OLANZAPINE (ZYPREXA), FLUOXETINE HYDROCHLORIDE (PROZAC), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), VITAMIN D3 and VITAMIN B COMPLEX (SUPER B COMPLEX [VITAMIN B COMPLEX]) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FACIAL PAIN (Pain in Left Cheek). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FACIAL PAIN (Pain in Left Cheek) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Severe itching all over the body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Severe itching all over the body) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PRURITUS (Severe itching all over the body). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PRURITUS (Severe itching all over the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Doctor gave patient a steroid shot and put her on Steroid pack.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included LOSARTAN for Blood pressure high, VITAMINS NOS (DAILY VITAMINS) and UBIDECARENONE (COQ 10) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VERTIGO (Vertigo). On 25-Mar-2021, VERTIGO (Vertigo) had resolved.            The patient reported the event after the second vaccine was not as bad as the first but she did get an aura for which she laid on the floor to prevent injury. No other treatment information was provided.   This case was linked to MOD-2021-235399 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow up received on 24-Jun-2021 and contain significant information. Added patient details, updated concomitant drug information. Updated outcome of the event vertigo.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain
Clinical narrative: severe sore throat; tested for COVID and was positive; This spontaneous case was reported by a nurse and describes the occurrence of OROPHARYNGEAL PAIN (severe sore throat) and COVID-19 (tested for COVID and was positive) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (severe sore throat) and COVID-19 (tested for COVID and was positive). At the time of the report, OROPHARYNGEAL PAIN (severe sore throat) and COVID-19 (tested for COVID and was positive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided     This case was linked; Sender's Comments: Crosslink
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Pruritus, Rash, Urticaria
Clinical narrative: Rash and hives all over body; nausea and vomiting; nausea and vomiting; 3 week Delayed reaction; severe diarrhea; Itchy feet; Rash and hives all over body; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (3 week Delayed reaction), DIARRHEA (severe diarrhea), PRURITUS (Itchy feet), RASH (Rash and hives all over body) and URTICARIA (Rash and hives all over body) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION COMPLICATION (3 week Delayed reaction), DIARRHEA (severe diarrhea), PRURITUS (Itchy feet), RASH (Rash and hives all over body), NAUSEA (nausea and vomiting) and VOMITING (nausea and vomiting). On an unknown date, the patient experienced URTICARIA (Rash and hives all over body). At the time of the report, VACCINATION COMPLICATION (3 week Delayed reaction), DIARRHEA (severe diarrhea), PRURITUS (Itchy feet), RASH (Rash and hives all over body), URTICARIA (Rash and hives all over body), NAUSEA (nausea and vomiting) and VOMITING (nausea and vomiting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not provided. Treatment products were not provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication, Vomiting
Clinical narrative: Rash and hives all over body; nausea and vomiting; nausea and vomiting; 3 week Delayed reaction; severe diarrhea; Itchy feet; Rash and hives all over body; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (3 week Delayed reaction), DIARRHEA (severe diarrhea), PRURITUS (Itchy feet), RASH (Rash and hives all over body) and URTICARIA (Rash and hives all over body) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION COMPLICATION (3 week Delayed reaction), DIARRHEA (severe diarrhea), PRURITUS (Itchy feet), RASH (Rash and hives all over body), NAUSEA (nausea and vomiting) and VOMITING (nausea and vomiting). On an unknown date, the patient experienced URTICARIA (Rash and hives all over body). At the time of the report, VACCINATION COMPLICATION (3 week Delayed reaction), DIARRHEA (severe diarrhea), PRURITUS (Itchy feet), RASH (Rash and hives all over body), URTICARIA (Rash and hives all over body), NAUSEA (nausea and vomiting) and VOMITING (nausea and vomiting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not provided. Treatment products were not provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and CHILLS (Chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced HEADACHE (Headache) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Pain, Pain in extremity
Clinical narrative: Arm pain; Can not sleep; Body pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), INSOMNIA (Can not sleep) and PAIN (Body pain) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included Fibromyalgia, Chronic fatigue and Multiple chemical sensitivity. Concurrent medical conditions included Allergy.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), INSOMNIA (Can not sleep) and PAIN (Body pain). At the time of the report, PAIN IN EXTREMITY (Arm pain), INSOMNIA (Can not sleep) and PAIN (Body pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Event outcome: Unknow to recovered updated.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: Back pain.; His left arm started hurting; A spontaneous report was received from a consumer concerning a 76-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events his left arm started hurting and back pain. The patient's medical history was not provided. Concomitant medications reported were Aleve for drug use for unknown indication.  On 3 Mar 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: Undisclosed) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 23 Mar 2021, the patient experienced the events his left arm started hurting and on unknown date experienced event back pain.He consented to be followed up by safety  Treatment details included, patient has not received  for his symptom left arm started hurting and He is on Aleve for his back pain  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of events, his left arm started hurting  and back pain was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Influenza like illness, Pain, Pyrexia
Clinical narrative: fever of 99.6 degrees Fahrenheit; felt like the flu; Temperature of 101.9 degrees Fahrenheit; sore; A spontaneous report  was received from a consumer concerning a 58-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore, temperature of 101.9 degrees fahrenheit, felt like the flu, fever of 99.6 degrees fahrenheit.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 23 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 036A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 24 Mar 2021, the patient experienced the event(s) sore, temperature of 101.9 degrees fahrenheit, felt like the flu. On 25 Mar 2021, the patient experienced the event(s) fever of 99.6 degrees fahrenheit.Caller did not consent for safety team to contact her HCP.  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), sore, temperature of 101, 9 degrees fahrenheit, felt like the flu, fever of 99, 6 degrees fahrenheit was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Somnolence, Tremor, Vomiting
Clinical narrative: vomit; shaking; sleepy; Chills; fever 100 degree; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), SOMNOLENCE (sleepy), CHILLS (Chills), PYREXIA (fever 100 degree) and VOMITING (vomit) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced TREMOR (shaking), SOMNOLENCE (sleepy), CHILLS (Chills) and PYREXIA (fever 100 degree). On 25-Mar-2021, the patient experienced VOMITING (vomit). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) at an unspecified dose and frequency. At the time of the report, TREMOR (shaking), SOMNOLENCE (sleepy), CHILLS (Chills), PYREXIA (fever 100 degree) and VOMITING (vomit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Body temperature: 100f.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Left fore arm itchy; had "piquetitos" (like itchy); Left fore arm red; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Left fore arm itchy), PRURITUS (had "piquetitos" (like itchy)) and ERYTHEMA (Left fore arm red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PRURITUS (had "piquetitos" (like itchy)) and ERYTHEMA (Left fore arm red). On an unknown date, the patient experienced PRURITUS (Left fore arm itchy). The patient was treated with NAPROXEN at an unspecified dose and frequency. At the time of the report, PRURITUS (Left fore arm itchy), PRURITUS (had "piquetitos" (like itchy)) and ERYTHEMA (Left fore arm red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 25-Mar-2021: Follow up received on 25 Mar 2021 contains updated event, start date of event n patient tab, Treatment details, vaccination date, updated  site of administration and facility name,  updated date of birth and relevant history
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on her chest; A spontaneous report was received from a healthcare professional concerning a 50-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash on her chest.  The patient's medical history was not provided. Concomitant medications reported were birth control pills, over the counter allergy medications.  On 22 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 006B21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 22 Mar 2021, the patient experienced the event, rash on her chest. It is localized in the top middle part of her chest, underneath the collar bone and is the size of her palm. Follow up with safety given. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, rash on her chest was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: 15 minutes after vaccine was given he developed rash from his wrist to elbows in both arm; Hives on neck; Rash on neck; A spontaneous report was received from a consumer concerning a 73-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events 15 minutes after vaccine was given he developed rash from his wrist to elbows in both arms, hives on neck, rash on neck.  The patient's medical history include hypertension, GERD(gastroesophageal reflux disease), barrett's esophagus. Concomitant medications reported were benazepril 20mg once daily, atorvastatin 20mg once daily, tamsulosin 0.4mg once daily, memantine 10mg twice daily,atomoxetine 25mg twice daily, omeprazole 40mg once daily for drug use for unknown indication.  On 8 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 025A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 8 Mar 2021, the patient experienced the events15 minutes after vaccine was given he developed rash from his wrist to elbows in both arms, hives on neck, rash on neck.Consent for safety follow up She told me that the second Moderna vaccine is not recommended because of these Adverse Events, that recommendation was given from their physician and CDC, as per the wife.  Treatment details included dexamethasone for hives and rash.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, 15 minutes after vaccine was given he developed rash from his wrist to elbows in both arms, hives on neck, rash on neck was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: she was diagnosed with COVID; A spontaneous report was received from a consumer concerning a 46-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events she was diagnosed with covid.  The patient's medical history was not provided. Concomitant medications reported were levothyroxine, albuterol Inhaler for drug use for unknown indication.  On 19 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 003B21A) intramuscularly for prophylaxis of COVID-19 infection.  On 21 Mar 2021, the patient experienced the evens she was diagnosed with covid.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, she was diagnosed with covid was unknown.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Device leakage, Underdose
Clinical narrative: Vanishing Needle Leaked; received less than half dose; This spontaneous case was reported by a health care professional and describes the occurrence of DEVICE LEAKAGE (Vanishing Needle Leaked) and UNDERDOSE (received less than half dose) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced DEVICE LEAKAGE (Vanishing Needle Leaked) and UNDERDOSE (received less than half dose). On 24-Mar-2021, DEVICE LEAKAGE (Vanishing Needle Leaked) and UNDERDOSE (received less than half dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Fever of 100 F; on and off headache; Tired that night; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100 F), FATIGUE (Tired that night) and HEADACHE (on and off headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced FATIGUE (Tired that night). On 24-Mar-2021, the patient experienced PYREXIA (Fever of 100 F) and HEADACHE (on and off headache). On 24-Mar-2021, PYREXIA (Fever of 100 F) and FATIGUE (Tired that night) had resolved. At the time of the report, HEADACHE (on and off headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  Treatment information include paracetamol.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Followup email received on 11-May-2021 contains no new information
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness, Hypotension, Palpitations, Paraesthesia oral
Clinical narrative: Adverse reaction; Felt a weird taste on the tong; The tong and lips were tingling pretty bad; Blood pressure dropped; Felt their heart was pounding out of their chest; had tachycardia; Thought they would pass out; Ear ringing; Felt dizzy; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (Adverse reaction), TASTE DISORDER (Felt a weird taste on the tongue), PARAESTHESIA ORAL (The tongue and lips were tingling pretty bad), HYPOTENSION (Blood pressure dropped) and PALPITATIONS (Felt their heart was pounding out of their chest) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DOXYLAMINE SUCCINATE for Sleep disturbance, THYROID (ARMOUR THYROID), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), PROGESTERONE and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION COMPLICATION (Adverse reaction), TASTE DISORDER (Felt a weird taste on the tongue), PARAESTHESIA ORAL (The tongue and lips were tingling pretty bad), HYPOTENSION (Blood pressure dropped), PALPITATIONS (Felt their heart was pounding out of their chest), TACHYCARDIA (had tachycardia), PRESYNCOPE (Thought they would pass out), TINNITUS (Ear ringing) and DIZZINESS (Felt dizzy). On 25-Mar-2021, HYPOTENSION (Blood pressure dropped) had resolved. At the time of the report, VACCINATION COMPLICATION (Adverse reaction), TASTE DISORDER (Felt a weird taste on the tongue), PARAESTHESIA ORAL (The tongue and lips were tingling pretty bad), PALPITATIONS (Felt their heart was pounding out of their chest), TACHYCARDIA (had tachycardia), PRESYNCOPE (Thought they would pass out), TINNITUS (Ear ringing) and DIZZINESS (Felt dizzy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Blood pressure measurement: 70 mmHg (Low) blood pressure reached down to 70. On 24-Mar-2021, Blood pressure measurement: 102/60 mmHg (Low) 102/60mmHg. On 25-Mar-2021, Blood pressure measurement: 118/80 mmHg (normal) 118/80mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included over the counter allergy medication, not specified. The urgent care doctors recommended to stay well hydrated.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jul-2021: Significant follow up received, treatment medication Doxylamine Succinate added.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Presyncope, Tachycardia, Taste disorder, Tinnitus, Vaccination complication
Clinical narrative: Adverse reaction; Felt a weird taste on the tong; The tong and lips were tingling pretty bad; Blood pressure dropped; Felt their heart was pounding out of their chest; had tachycardia; Thought they would pass out; Ear ringing; Felt dizzy; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (Adverse reaction), TASTE DISORDER (Felt a weird taste on the tongue), PARAESTHESIA ORAL (The tongue and lips were tingling pretty bad), HYPOTENSION (Blood pressure dropped) and PALPITATIONS (Felt their heart was pounding out of their chest) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DOXYLAMINE SUCCINATE for Sleep disturbance, THYROID (ARMOUR THYROID), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), PROGESTERONE and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION COMPLICATION (Adverse reaction), TASTE DISORDER (Felt a weird taste on the tongue), PARAESTHESIA ORAL (The tongue and lips were tingling pretty bad), HYPOTENSION (Blood pressure dropped), PALPITATIONS (Felt their heart was pounding out of their chest), TACHYCARDIA (had tachycardia), PRESYNCOPE (Thought they would pass out), TINNITUS (Ear ringing) and DIZZINESS (Felt dizzy). On 25-Mar-2021, HYPOTENSION (Blood pressure dropped) had resolved. At the time of the report, VACCINATION COMPLICATION (Adverse reaction), TASTE DISORDER (Felt a weird taste on the tongue), PARAESTHESIA ORAL (The tongue and lips were tingling pretty bad), PALPITATIONS (Felt their heart was pounding out of their chest), TACHYCARDIA (had tachycardia), PRESYNCOPE (Thought they would pass out), TINNITUS (Ear ringing) and DIZZINESS (Felt dizzy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Blood pressure measurement: 70 mmHg (Low) blood pressure reached down to 70. On 24-Mar-2021, Blood pressure measurement: 102/60 mmHg (Low) 102/60mmHg. On 25-Mar-2021, Blood pressure measurement: 118/80 mmHg (normal) 118/80mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included over the counter allergy medication, not specified. The urgent care doctors recommended to stay well hydrated.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jul-2021: Significant follow up received, treatment medication Doxylamine Succinate added.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, SARS-CoV-2 test false positive
Clinical narrative: Having side effects from the vaccine which cannot be differentiated between those of COVID, she feels like "crap"; False positive test result; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events having side effects from the vaccine which cannot be differentiated between those of covid, she, false positive test result.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Jan 1900, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events having side effects from the vaccine which cannot be differentiated between those of COVID, she, false positive test result.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, having side effects from the vaccine which cannot be differentiated between those of covid, she, false positive test result was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Fever; Chills; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Slight headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Slight headache). At the time of the report, PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up received on 11-MAY-2021. It contains No New Information.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itchiness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness in her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PRURITUS (itchiness in her arm). At the time of the report, PRURITUS (itchiness in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Migraine, Nausea, Petechiae
Clinical narrative: Petechiae Lower Extremities; Delayed reaction, COVID ARM 15CM; Itching on the head, arm and chest; Migraine attack X 1 (Took medicine before it became a full blown attack); Pain at the Injection Site; Swelling; Fatigue; Nauseous; This spontaneous case was reported by a physician and describes the occurrence of MIGRAINE (Migraine attack X 1 (Took medicine before it became a full blown attack)), PETECHIAE (Petechiae Lower Extremities), DIZZINESS (Itching on the head, arm and chest), VACCINATION SITE REACTION (Delayed reaction, COVID ARM 15CM) and VACCINATION SITE PAIN (Pain at the Injection Site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Migraine (No reported medical history).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at the Injection Site), VACCINATION SITE SWELLING (Swelling), FATIGUE (Fatigue) and NAUSEA (Nauseous). On 13-Mar-2021, the patient experienced MIGRAINE (Migraine attack X 1 (Took medicine before it became a full blown attack)). On 20-Mar-2021, the patient experienced DIZZINESS (Itching on the head, arm and chest). On 21-Mar-2021, the patient experienced VACCINATION SITE REACTION (Delayed reaction, COVID ARM 15CM). On 22-Mar-2021, the patient experienced PETECHIAE (Petechiae Lower Extremities). On 13-Mar-2021, MIGRAINE (Migraine attack X 1 (Took medicine before it became a full blown attack)) had resolved. On 15-Mar-2021, VACCINATION SITE PAIN (Pain at the Injection Site), VACCINATION SITE SWELLING (Swelling) and NAUSEA (Nauseous) had resolved. On 25-Mar-2021, DIZZINESS (Itching on the head, arm and chest) and VACCINATION SITE REACTION (Delayed reaction, COVID ARM 15CM) had resolved. At the time of the report, PETECHIAE (Petechiae Lower Extremities) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided